Collectively, these results showed that HDAC1,2 activity are required for BBAP-catalyzed active H4K91ub1 to occur when DLBCL cells are exposed to doxorubicin, a chemotherapy drug and a DNA-damaging agent. The gene discussed is DTX3L; the disease is diffuse large B-cell lymphoma.